These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13626096)

  • 1. [Result of double vaccination against Q fever].
    KULAGIN SM; FUKI AD; ZUBKOVA RI; POPOVA LD
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Nov; 29(11):25-9. PubMed ID: 13626096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Result of mass vaccination against Q fever. II. Remote results of vaccination].
    ZUBKOVA RI; FEDOROVA NI; KALMYKOV NL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Nov; 27(11):18-20. PubMed ID: 13410087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in mass vaccination against Q fever. I. Capacity of Q fever vaccine to produce reactivity and immunity].
    ZUBKOVA RI; FEDOROVA NI; KALMYKOV NL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):24-7. PubMed ID: 13353714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specific vaccination against Q fever].
    FEDOROVA NI; TAV'EV BM; RUMIANTSEVA EV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Aug; 29(8):75-80. PubMed ID: 13605068
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination of sheep against Q fever].
    SHIFRIN Ia; ROZHKOV FV; TRUBA IV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Aug; 29(8):97-101. PubMed ID: 13605074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Solution of active specific prevention of Q fever. II. Experiences with vaccination against Q fever in man].
    VASIL'EVA LV; IABLONSKAIA VA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jun; 6():50-4. PubMed ID: 13248125
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in preparation of vaccine against Q fever].
    KHODUKIN NI; SHTERNGOL'D EIa; SHLEIKHER EI; ZVAGEL'SKAIA VN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):22-3. PubMed ID: 13353713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Active specific prevention of Q-fever].
    SOMOVA AG; GERASIUK LG
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Nov; 27(11):12-7. PubMed ID: 13410086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Result of the mass immunization of the human population with the M-44 vaccine against Q fever. I. Subcutaneous method of immunization].
    Genig VA; Kniazeva EN; Tsel'nikov PS; Miroshnichenko MM
    Vopr Virusol; 1965; 10(3):319-23. PubMed ID: 5885357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with vaccination of humans against Q fever in Czechoslovakia].
    Kazár J; Brezina R; Schramek S; Kovácová E; Urvölgyi J; Tvrdá B; Palanová A
    Bratisl Lek Listy; 1983 Jul; 80(1):31-40. PubMed ID: 6616283
    [No Abstract]   [Full Text] [Related]  

  • 11. [Examination of cattle for Q fever by means of milk capillary agglutination reaction in north-eastern parts of Poland].
    TWOREK R; SEROKOWA D
    Przegl Epidemiol; 1959; 13():273-6. PubMed ID: 13840077
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine prophylaxis of abattoir-associated Q fever.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick D; Cameron S; Esterman A; Feery B; Collins W
    Lancet; 1984 Dec; 2(8417-8418):1411-4. PubMed ID: 6151039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disinfection of various objects infected by Rickettsia burneti].
    KULAGIN SM; SOKOLOVA NF
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Nov; 27(11):43-5. PubMed ID: 13410094
    [No Abstract]   [Full Text] [Related]  

  • 14. Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.
    Sellens E; Norris JM; Dhand NK; Heller J; Hayes L; Gidding HF; Willaby H; Wood N; Bosward KL
    PLoS One; 2016; 11(1):e0146819. PubMed ID: 26756210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q-fever vaccination--unfinished business in Australia.
    Massey PD; Durrheim DN; Way A
    Vaccine; 2009 Jun; 27(29):3801. PubMed ID: 19393710
    [No Abstract]   [Full Text] [Related]  

  • 16. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA; Franklin LJ; Sutton B; Firestone SM
    Vaccine; 2017 Dec; 35(51):7084-7087. PubMed ID: 29132996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.
    Vermeer-de Bondt PE; Schoffelen T; Vanrolleghem AM; Isken LD; van Deuren M; Sturkenboom MC; Timen A
    PLoS One; 2015; 10(4):e0123570. PubMed ID: 25909712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?
    Bults M; Beaujean DJ; Wijkmans CJ; Timen A; Richardus JH; Voeten HA
    Vaccine; 2012 May; 30(23):3369-75. PubMed ID: 22475862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in mass immunization of humans with the M-44 live vaccine against Q-fever. 2. Skin and oral routes of immunization].
    Genig VA
    Vopr Virusol; 1965; 10(6):703-7. PubMed ID: 4225871
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011.
    Schoffelen T; Wong A; Rümke HC; Netea MG; Timen A; van Deuren M; Vermeer-de Bondt PE
    Vaccine; 2014 Nov; 32(49):6622-30. PubMed ID: 25446824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.